WO2006052231A1 - Ready to drink beverage composition - Google Patents

Ready to drink beverage composition Download PDF

Info

Publication number
WO2006052231A1
WO2006052231A1 PCT/US2004/036572 US2004036572W WO2006052231A1 WO 2006052231 A1 WO2006052231 A1 WO 2006052231A1 US 2004036572 W US2004036572 W US 2004036572W WO 2006052231 A1 WO2006052231 A1 WO 2006052231A1
Authority
WO
WIPO (PCT)
Prior art keywords
approximately
isoleucine
valine
leucine
arginine
Prior art date
Application number
PCT/US2004/036572
Other languages
French (fr)
Inventor
Jeffrey Liebrecht
Original Assignee
Taylor, Matthew, F.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taylor, Matthew, F. filed Critical Taylor, Matthew, F.
Priority to PCT/US2004/036572 priority Critical patent/WO2006052231A1/en
Publication of WO2006052231A1 publication Critical patent/WO2006052231A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • This invention relates to a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, in particular, the invention relates to a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth.
  • Such nutrients have been supplied by ingesting diets that provide the necessary amounts of protein (the source of amino acids), calories and other nutrients.
  • Powders that contain the appropriate amino acids are available in cans and jars that come with scoopers for measuring dosages into a glass to which water or other beverage is to be added.
  • the problems with this prior art are: consuming the powder dry is very difficult, and many of the powders taste bad, even if mixed with water; if mixed with juice or milk, the fructose or lactose of the juice/milk raises blood glucose and insulin levels.
  • Such products are, however, generally unpalatable and do not, in fact, satisfy the body completely by replenishing all the essential constituents which are lost.
  • One object of the present invention is to provide a new method of stimulating production of HGH for natural muscle growth stimulation, in the form of a tasty, convenient ready-to-drink beverage.
  • the provision of an agonist/inhibition blockade to HGH Releasing Factor is the premise of the use of L-Arginine at basal metabolic levels. Until now, these were only available in a powder barely palatable form because of technical and biochemical difficulty in creating a product that is bioavailable. To stimulate HGH production in this manner goes against the teaching of the prior art because it was believed not to be possible to combine the necessary amino acids with any food for the reasons stated above.
  • the delivery system of the present invention therefore combines the preferred amino acid dosages with ready-to- drink beverages that taste good and are convenient, as opposed to the prior art of powders and numerous pills.
  • the present invention provides a multi-electrolyte composition including water, fructose, inulin, and flavoring to provide a more palatable drink with a better balance of electrolytes and HGH.
  • This isotonic energy drink also includes critical vitamins and minerals as important nutrients for muscle growth and optimum performance.
  • the invention comprises a ready to drink beverage product for direct increase of human growth hormone (HGH).
  • HGH human growth hormone
  • Simple sugars and critical vitamins and minerals are blended in water to provide an electrolyte solution for daily consumption to stimulate muscle growth. It is, therefore, an object of the present invention to enable beverage compositions for use in growth stimulation that avoids the disadvantages of the prior art.
  • a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, containing optimum quantities of sugars, slats and minerals, including essential amino acids is disclosed.
  • a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth is described.
  • a ready to drink beverage having a liquid form HGH pre-cursor is mixed together using water, sweeteners, citric acid, flavoring and a blend of vitamins and minerals.
  • the combination of vitamins and minerals includes Pantothenic Acid, Boron, Chromium, Copper, and Choline. Additional ingredients include L-Arginine, L-Isoleucine, L-Leucine, and L- Valine.
  • a powder premixture comprising the following composition:
  • Pantothenic Acid (as D-Calcium Pantothenate, USP) 2 - 8 mg Boron (as Sodium Borate, USP) 0.5 - 2 mg
  • Chromium (as Chromium Chloride (6H 2 O), USP) 10 - 15 meg
  • the premixture contains:
  • Pantothenic Acid (as D-Calcium Pantothenate, USP) approximately 5 mg
  • Chromium (as Chromium Chloride (6H 2 O), USP) approximately 12 meg
  • Maltodextrin (as Maltrin M- 100) Q.S.
  • the beverage is prepared by heating a quantity of water to approximately
  • the admixture is sterilized and homogenized.
  • the solution is heated to approximately 200 0 F for about 10 seconds at lOOOpsi. While still hot, the solution is placed in bottles, sealed and quick cooled, by plunging a sealed bottle in an ice bath.
  • Each 8-ounce serving comprises the following approximate constituents:
  • Sweetener-Splenda MNP approximately 0.064 g
  • Acesulfame-K (Potassium)-Sweetener RCC approximately 0.027 g
  • Citric Acid-Anhydrous (Acidulent) HRC approximately 6.5 g
  • the beverage is blended to provide the following approximate components:
  • Each 8-ounce serving contains the following approximate nutrients per serving:
  • L-Arginine is known to be a human growth hormone precursor that stimulates the pituitary gland, which controls body growth.
  • the beverage is consumed on a daily basis, preferably at night before sleeping. While the body is at rest, the HGH works to stimulate muscle growth naturally.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

This invention relates to novel compositions and methods for creating such composition that can be ingested by humans as a dietary supplement that can be used by athletes and bodybuilders for restoring human growth hormones. The novel compositions comprise fluids containing water, sugar including the carbohydrates, fructose and maltodextrin, and electrolytes chromium, copper, potassium, magnesium, sodium, and citric acid. The composition also includes selected amino acids such as leucine, isoleucine, valine and arginine.

Description

The title is too long; "READY TO DRINK BEVERAGE COMPOSITION" is suggested.
Technical Field
This invention relates to a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, in particular, the invention relates to a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth.
Background Art There are presently a substantial number of electrolyte drinks on the market that are alleged to replenish essential electrolytes and water lost from the body during physical activity. Physical exercise can be distinguished in different categories i.e. those requiring strength, strength and speed or endurance. In practice, this can be heavy work, muscle activity under severe conditions (e.g. high temperature, high altitude), leisure sports or athletic performance. Athletes who participate in sports at any level, amateur or professional, strive to bring their bodies to a physical state that is optimum for the sport or activity of interest. One factor that enables athletes to participate effectively is a high degree of development of the aerobic capacity and/or strength of skeletal muscle. The inherent problem is a built-in failure in stimulus of production and release of human growth hormone (HGH). The natural production of HGH incrementally decreases in the normal human being after approximately 23 years of age.
The desire to attain, in a rapid manner, the maximum degree of skeletal muscle adaptation to exercise has led some athletes to resort to the use of drugs. Such drugs, particularly steroids, are known to "force" muscle growth to degrees greater than can be achieved by exercise and diet alone. The use of such drugs is both illegal and dangerous. The side effects of steroids are dangerous and unacceptable. Indeed, all professional sports leagues, as well as collegiate athletics, have a long list of potentially performance enhancing substances, many of which may be over-the- counter products, the use of any of which is banned. It is therefore important to provide a natural growth stimulus that does not contain any of the banned ingredients. Muscle requires a large array of nutrients, including amino acids (which are derived from protein) for growth. Such nutrients have been supplied by ingesting diets that provide the necessary amounts of protein (the source of amino acids), calories and other nutrients. Powders that contain the appropriate amino acids are available in cans and jars that come with scoopers for measuring dosages into a glass to which water or other beverage is to be added. The problems with this prior art are: consuming the powder dry is very difficult, and many of the powders taste bad, even if mixed with water; if mixed with juice or milk, the fructose or lactose of the juice/milk raises blood glucose and insulin levels. Such products are, however, generally unpalatable and do not, in fact, satisfy the body completely by replenishing all the essential constituents which are lost.
One object of the present invention, then, is to provide a new method of stimulating production of HGH for natural muscle growth stimulation, in the form of a tasty, convenient ready-to-drink beverage. The provision of an agonist/inhibition blockade to HGH Releasing Factor is the premise of the use of L-Arginine at basal metabolic levels. Until now, these were only available in a powder barely palatable form because of technical and biochemical difficulty in creating a product that is bioavailable. To stimulate HGH production in this manner goes against the teaching of the prior art because it was believed not to be possible to combine the necessary amino acids with any food for the reasons stated above. The delivery system of the present invention therefore combines the preferred amino acid dosages with ready-to- drink beverages that taste good and are convenient, as opposed to the prior art of powders and numerous pills. The present invention provides a multi-electrolyte composition including water, fructose, inulin, and flavoring to provide a more palatable drink with a better balance of electrolytes and HGH. This isotonic energy drink also includes critical vitamins and minerals as important nutrients for muscle growth and optimum performance.
Disclosure of Invention
The invention comprises a ready to drink beverage product for direct increase of human growth hormone (HGH). Simple sugars and critical vitamins and minerals are blended in water to provide an electrolyte solution for daily consumption to stimulate muscle growth. It is, therefore, an object of the present invention to enable beverage compositions for use in growth stimulation that avoids the disadvantages of the prior art.
It is another object of the present invention to enable a method for preparing such beverage compositions. It is yet another object of the present invention to enable a beverage composition that stimulates production of HGH that typically diminishes with age.
It is more specifically an object of the invention to provide such a beverage composition that is pleasant tasting.
It is another object of the invention to provide a beverage composition having electrolytes in correct physiological quantities to increase the efficiency of the body to utilize sugars and improve muscular activities.
It is still a further object of the present invention to enable a beverage composition that does not contain ingredients that have been banned from use by professional athletes. In accordance with the above and other objects, a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, containing optimum quantities of sugars, slats and minerals, including essential amino acids is disclosed. In particular, a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth is described. The various features of novelty that characterize the invention will be pointed out with particularity in the claims of this application.
Best Models') for Carrying Out the Invention
The invention summarized above may be better understood by referring to the following description. This description of an embodiment, set out below to enable one to build and use an implementation of the invention, is not intended to limit the enumerated claims, but to serve as a particular example thereof. Those skilled in the art should appreciate that they may readily use the conception and specific embodiments disclosed as a basis for modifying or designing other methods and systems for carrying out the same purposes of the present invention. Those skilled in the art should also realize that such equivalent assemblies do not depart from the spirit and scope of the invention in its broadest form.
In a first embodiment, a ready to drink beverage having a liquid form HGH pre-cursor is mixed together using water, sweeteners, citric acid, flavoring and a blend of vitamins and minerals. The combination of vitamins and minerals includes Pantothenic Acid, Boron, Chromium, Copper, and Choline. Additional ingredients include L-Arginine, L-Isoleucine, L-Leucine, and L- Valine.
In a preferred embodiment, a powder premixture is formulated comprising the following composition:
Pantothenic Acid (as D-Calcium Pantothenate, USP) 2 - 8 mg Boron (as Sodium Borate, USP) 0.5 - 2 mg
Chromium (as Chromium Chloride (6H2O), USP) 10 - 15 meg
Copper (as Copper Sulfate) 0.1 - 0.4 mg
L-Isoleucine (USP) 15 - 45 mg
L-Leucine (USP) 30 - 75 mg L- Valine (USP) 15 - 45 mg
Choline (as Choline Bitartrate, FCC) 15 - 45 mg
Maltodextrin (as Maltrin M- 100) Q.S.
Approximately 225 mg of the premixture is used for an 8 fluid ounce serving. Preferably, the premixture contains:
Pantothenic Acid (as D-Calcium Pantothenate, USP) approximately 5 mg
Boron (as Sodium Borate, USP) approximately 1 mg
Chromium (as Chromium Chloride (6H2O), USP) approximately 12 meg
Copper (as Copper Sulfate) approximately 0.2 mg L-Isoleucine (USP) approximately 25 mg
L-Leucine (USP) approximately 50 mg
L- Valine (USP) approximately 25 mg
Choline (as Choline Bitartrate, FCC) approximately 25 mg
Maltodextrin (as Maltrin M- 100) Q.S. The beverage is prepared by heating a quantity of water to approximately
15O0F. A sufficient amount of Raftilose and Fructose are added and mixed
thoroughly until dissolved. A sufficient amount of Sucralose and Acesulfame-K are added and mixed thoroughly until dissolved. A quantity of premixture of the vitamins and minerals, and a sufficient amount of L-Arginine is added and mixed thoroughly until dissolved. Once the ingredients are thoroughly combined, flavoring and debittering agents are added. Next, a sufficient quantity of Citric Acid is added to adjust the pH to approximately 4.0.
Following blending of the beverage solution, the admixture is sterilized and homogenized. The solution is heated to approximately 2000F for about 10 seconds at lOOOpsi. While still hot, the solution is placed in bottles, sealed and quick cooled, by plunging a sealed bottle in an ice bath.
Each 8-ounce serving comprises the following approximate constituents:
Oligofructose-Raftilose P95-Pwd RHF approximately 2.95 g
Krystar Crystalline Fructose-Sweetener STC approximately 5.79 g
Sweetener-Splenda MNP approximately 0.064 g
Acesulfame-K (Potassium)-Sweetener RCC approximately 0.027 g
Premixture approximately 225 mg
Natural Flavor (OSF 1.01) approximately 2.72 g
Citric Acid-Anhydrous (Acidulent) HRC approximately 6.5 g
Water approximately 581.7 g
L-Arginine approximately 3 g
The beverage is blended to provide the following approximate components:
Figure imgf000007_0001
Each 8-ounce serving contains the following approximate nutrients per serving:
Figure imgf000007_0002
L-Arginine is known to be a human growth hormone precursor that stimulates the pituitary gland, which controls body growth. In a preferred embodiment, the beverage is consumed on a daily basis, preferably at night before sleeping. While the body is at rest, the HGH works to stimulate muscle growth naturally.

Claims

Claims What is claimed is: L A liquid beverage product for consumption by humans for restoring human growth hormone, said beverage product comprising: (A) pantothenic acid; (B) boron; (C) chromium; (D) copper; (E) isoleucine; (F) leucine; (G) valine; (H) choline; (I) arginine; and (J) water in a quantity at least sufficient for providing a solution wherein components (A) to (I) are substantially dissolved and which solution is ready for consumption by drinking. 2. The beverage product of Claim 1, in which the isoleucine is in the form of L-Isoleucine, the leucine is in the form of L-Leucine, the valine is in the form of L- Valine, and the arginine is in the form of L- Arginine. 3. The beverage product of Claim 1, wherein the ingredients consist of: (A) about 2 mg to about 8 mg of pantothenic acid; (B) about 0.5 mg to about 2 mg of boron; (C) about 10 meg to about 15 meg of chromium; (D) about 0.1 mg to about 0.4 mg of copper; (E) about 15 mg to about 45 mg of L-Isoleucine; (F) about 30 mg to about 75 mg of L-Leucine; (G) about 15 mg to about 45 mg of L- Valine; (H) about 15 mg to about 45 mg of choline; and (I) about 3000 mg of L- Arginine. 4. The beverage product of Claim 1, wherein the ingredients consist of: (A) approximately 5 mg of pantothenic acid; (B) approximately 1 mg of boron; (C) approximately 12 meg of chromium; (D) approximately 0.2 mg of copper; (E) approximately 25 mg of L-Isoleucine; (F) approximately 50 mg of L-Leucine; (G) approximately 25 mg of L- Valine; (H) approximately 25 mg of choline; and (I) approximately 3000 mg of L-Arginine. 5. A method of preparing a liquid beverage product for consumption by humans for restoring human growth hormone, said method comprising the steps of: (A) heating a quantity of water to approximately 15O0F; (B) adding a sufficient quantity of a natural sweetener and dissolving such sweetener in the water; (C) adding a sufficient quantity of a premixture and dissolving such premixture in the water; (D) adding a sufficient quantity of L-Arginine; (E) after thoroughly dissolving all ingredients in the water, adding flavoring and debittering agents and a sufficient quantity of citric acid to adjust the pH to approximately 4.0. 6. The method of Claim 5, in which such natural sweeteners are selected from the group consisting of: (A) Raftilose; (B) Fructose; (C) Sucralose; and (D) Acesulfame-K. 7. The method of Claim 5, in which such premixture comprises: (A) about 2 mg to about 8 mg of pantothenic acid; (B) about 0.5 mg to about 2 mg of boron; (C) about 10 meg to about 15 meg of chromium; (D) about 0.1 mg to about 0.4 mg of copper; (E) about 15 mg to about 45 mg of L-Isoleucine; (F) about 30 mg to about 75 mg of L-Leucine; (G) about 15 mg to about 45 mg of L- Valine; (H) about 15 mg to about 45 mg of choline. 7. The method of Claim 5, further comprising the steps of: (I) sterilizing and homogenizing such solution; and (J) dividing such solution into smaller quantities for bottling. 8. A method of supplementing the diet of a human to stimulate muscle growth comprising administering leucine, isoleucine, valine and arginine in combination with pantothenic acid, sodium, potassium, copper, chromium, chorine, and boron on a daily basis. 9. The method of Claim 8 wherein the isoleucine is in the form of L- Isoleucine, the leucine is in the form of L-Leucine, the valine is in the form of L- Valine, and the arginine is in the form of L- Arginine. 10. The method of Claim 8 wherein the arginine is administered in a dosage of approximately 3000 mg. 11. The method of Claim 8 wherein the leucine is administered in a dosage of about 30 mg to about 75 mg. 12. The method of Claim 8 wherein the isoleucine is administered in a dosage of about 15 mg to about 45 mg. 13. The method of Claim 8 wherein the valine is administered in a dosage of about 15 mg to about 45 mg. 14. The method of Claim 8 wherein the leucine is administered in a dosage of approximately 50 mg. 15. The method of Claim 8 wherein the isoleucine is administered in a dosage approximately 25 mg. 16. The method of Claim 8 wherein the valine is administered in a dosage of approximately 25 mg.
PCT/US2004/036572 2004-11-03 2004-11-03 Ready to drink beverage composition WO2006052231A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2004/036572 WO2006052231A1 (en) 2004-11-03 2004-11-03 Ready to drink beverage composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/036572 WO2006052231A1 (en) 2004-11-03 2004-11-03 Ready to drink beverage composition

Publications (1)

Publication Number Publication Date
WO2006052231A1 true WO2006052231A1 (en) 2006-05-18

Family

ID=36336798

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/036572 WO2006052231A1 (en) 2004-11-03 2004-11-03 Ready to drink beverage composition

Country Status (1)

Country Link
WO (1) WO2006052231A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011073187A1 (en) * 2009-12-15 2011-06-23 Givaudan Sa Aftertaste masking
WO2013002802A1 (en) * 2011-06-30 2013-01-03 Taylor, Matthew Ready to drink beverage composition
US8932647B1 (en) * 2013-08-11 2015-01-13 Matthew F. Taylor, Jr. Functional beverage composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340483B1 (en) * 2000-08-03 2002-01-22 Diepon, S.A. Antiviral composition derived from allium CEPA and therapeutic use thereof
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340483B1 (en) * 2000-08-03 2002-01-22 Diepon, S.A. Antiviral composition derived from allium CEPA and therapeutic use thereof
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011073187A1 (en) * 2009-12-15 2011-06-23 Givaudan Sa Aftertaste masking
CN102655766A (en) * 2009-12-15 2012-09-05 奇华顿股份有限公司 Aftertaste masking
CN102655766B (en) * 2009-12-15 2013-12-25 奇华顿股份有限公司 Aftertaste masking
WO2013002802A1 (en) * 2011-06-30 2013-01-03 Taylor, Matthew Ready to drink beverage composition
US8932647B1 (en) * 2013-08-11 2015-01-13 Matthew F. Taylor, Jr. Functional beverage composition

Similar Documents

Publication Publication Date Title
US5891888A (en) Physical endurance drink
US4871550A (en) Nutrient composition for athletes and method of making and using the same
US20050064070A1 (en) Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same
ES2269175T3 (en) METHOD TO PREPARE POTENTIAL FOOD SUPPLEMENTS OF CARTILAGO.
US20040175443A1 (en) Food supplement for increasing lean mass and strength
TW200410680A (en) Nutritiona compositions
CN1220583A (en) Improvements in or relating to compositions containing creatine
EP0625312B1 (en) Feeding composition
AU4286493A (en) Improved endurance and rehydration composition
US20090186098A1 (en) Sports drink composition
US20060172016A1 (en) Muscle cramp reliever
MacDonald et al. Protein substitutes for PKU: what's new?
WO2007143660A1 (en) Reducing muscle soreness with glucosamine compositions
ES2792829T3 (en) Functional and stable protein mixture for food compositions intended for people who need an improvement and maintenance of their physical condition
US20030104107A1 (en) Energy drink formula and method
US20020037830A1 (en) Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementation and an energy supplement containing such an additive
US20070248648A1 (en) High protein, fatigue reducing powder
US20050064013A1 (en) Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
WO2013002802A1 (en) Ready to drink beverage composition
WO2006052231A1 (en) Ready to drink beverage composition
JPS61215323A (en) Nutrient food and drink
US8932647B1 (en) Functional beverage composition
US20190365707A1 (en) Methods of ameliorating post-dialysis washout and nutritional supplements for use in such methods
WO2006052230A1 (en) Beverage compositions for use in rehydration and mutrition during athletic exercise and methods of making same
JPH01269456A (en) Food for sport

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 04800644

Country of ref document: EP

Kind code of ref document: A1